I can't get inside his head, but as I was alluding to earlier he had envisioned 3 parts to this company. It would seem more feasible that (like Abbott attempted to do last year) sell off its diagnostic portion of the company. We will have a revenue stream with NO OVERHEAD. It is hard to give that up. This is a worldwide test. Like you said, though, money does talk.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.